Nanomedicine News

RSS

Zetasizer Nano From Malvern Instruments Being Used To Study Particulate Vaccines

Researchers in the Department of Pharmaceutics and Biopharmaceutics at Kiel University in Germany, are using a Zetasizer Nano system from Malvern Panalytical in their work on particulate vaccines formulations for administration via the respiratory tract.

From Malvern Panalytical 15 Oct 2013

Spinning Disk Statistical Imaging System Helps Visualize Protein Structures and Sub-Cellular Macromolecules

The microscopic technique, developed by researchers at Queen Mary University of London, represents a major advance for cell biologists as it will allow them to investigate structures deep inside the cell, such as viruses, bacteria and parts of the nucleus in depth.

11 Oct 2013

Poster on Thermo-Responsive Layer-by-Layer Assemblies for Nanoparticle-Based Drug Delivery Advances to ISPE’s National Competition

Jing Zhou, a graduate student in the Department of Biomedical Engineering at Texas A&M University, has received top honors at the International Society of Pharmaceutical Engineering (ISPE), South Central Chapter research poster competition, hosted by the National Center for Therapeutics Manufacturing.

10 Oct 2013

New Investment for Development of CNSE’s RNA Technology by Hocus Locus

Governor Andrew M. Cuomo today announced that the RNA technology invented at CNSE will be developed by Albany-based Hocus Locus, LLC with a recent investment from Eastern New York Angels. Once developed, the technology will provide medical researchers and healthcare providers with a new diagnostic tool to aid in the detection of cancer and other diseases. Its creators say the technology could also lead to the development of new treatments for those diseases.

From College of Nanoscale Science and Engineering, University at Albany 10 Oct 2013

Development of Nanoparticle Technology-Based Mucosal Vaccines Receives SEK 16 Million Funding

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines.

9 Oct 2013

NanoViricides Initiates Non-GLP Toxicology Evaluation of Optimized Injectable FluCide

NanoViricides, Inc., reports that it has initiated the initial non-GLP toxicology evaluation of its optimized injectable FluCide® drug candidate. This study is an important step in the drug development pathway for FluCide.

9 Oct 2013

Genisphere Enhances 3DNA Nanotechnology for Universal Signal Amplification System Applications

Genisphere LLC reported today it has adapted its 3DNA® Nanotechnology for use as a universal signal amplification system for improving the sensitivity and overall performance of rapid diagnostic tests and applications.

8 Oct 2013

Novavax Begins Enrollment in RSV Vaccine Phase 2 Dose-Confirmatory Clinical Trial

Novavax, Inc. today announced that enrollment has begun in a Phase 2 dose-confirmatory clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age.

From Novavax Inc. 8 Oct 2013

Mammalian Cells Prefer Disc-Shaped Rather Than Rod-Shaped Nanoparticles

For years scientists have been working to fundamentally understand how nanoparticles move throughout the human body. One big unanswered question is how the shape of nanoparticles affects their entry into cells. Now researchers have discovered that under typical culture conditions, mammalian cells prefer disc-shaped nanoparticles over those shaped like rods.

From Georgia Institute of Technology 8 Oct 2013

Tekmira Presents Additional TKM-PLK1 Data at 6th Annual NET Conference

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that it presented additional TKM-PLK1 data at the 6th Annual NET Conference hosted by the North American Neuroendocrine Tumor Society (NA-NETS) to be held in Charleston, South Carolina from October 4-5, 2013.

5 Oct 2013

Nanomedicine News

Zetasizer Nano From Malvern Instruments Being Used To Study Particulate Vaccines

Spinning Disk Statistical Imaging System Helps Visualize Protein Structures and Sub-Cellular Macromolecules

Poster on Thermo-Responsive Layer-by-Layer Assemblies for Nanoparticle-Based Drug Delivery Advances to ISPE’s National Competition

New Investment for Development of CNSE’s RNA Technology by Hocus Locus

Development of Nanoparticle Technology-Based Mucosal Vaccines Receives SEK 16 Million Funding

NanoViricides Initiates Non-GLP Toxicology Evaluation of Optimized Injectable FluCide

Genisphere Enhances 3DNA Nanotechnology for Universal Signal Amplification System Applications

Novavax Begins Enrollment in RSV Vaccine Phase 2 Dose-Confirmatory Clinical Trial

Mammalian Cells Prefer Disc-Shaped Rather Than Rod-Shaped Nanoparticles

Tekmira Presents Additional TKM-PLK1 Data at 6th Annual NET Conference

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting